n-(3-(aminomethyl)benzyl)acetamidine and Hypercholesterolemia studies

N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.

Hypercholesterolemia: A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.

Research Excerpts

Excerpt	Relevance	Reference
"The aim of the current study was to determine whether hypercholesterolemia affects the delayed sevoflurane preconditioning against myocardial ischemia-reperfusion (IR) injury and, if so, the underlying mechanism."	7.78	Hypercholesterolemia abrogates sevoflurane-induced delayed preconditioning against myocardial infarct in rats by alteration of nitric oxide synthase signaling. ( Chen, G; Ma, LL; Qian, LB; Wang, WN; Yan, M; Yang, MJ; Yu, J; Yu, LN; Zhang, FJ, 2012)
"The aim of the current study was to determine whether hypercholesterolemia affects the delayed sevoflurane preconditioning against myocardial ischemia-reperfusion (IR) injury and, if so, the underlying mechanism."	3.78	Hypercholesterolemia abrogates sevoflurane-induced delayed preconditioning against myocardial infarct in rats by alteration of nitric oxide synthase signaling. ( Chen, G; Ma, LL; Qian, LB; Wang, WN; Yan, M; Yang, MJ; Yu, J; Yu, LN; Zhang, FJ, 2012)

Research

Studies (1)

Authors

Other Studies

1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and Hypercholesterolemia

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors	Studies
Zhang, FJ	1
Ma, LL	1
Wang, WN	1
Qian, LB	1
Yang, MJ	1
Yu, J	1
Chen, G	1
Yu, LN	1
Yan, M	1